Recall Register

Food, drugs, devices › Philips North America

Device recall: IntelliVue Patient Monitor MX400 (Model Number 866060), MX430 (Model Number 866061), MX450 (Model Number 866062), MX500

FDA enforcement event 95295 · Class II · initiated 30 Aug 2024 · status Ongoing

DeviceVoluntary: Firm initiated1 product recordCambridge, MA

FDA enforcement event 95295 is a device recall by Philips North America of Cambridge, MA, initiated 30 Aug 2024 and classified Class II, with 1 product record.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 87% of the 970 device enforcement events initiated in 2024 carry the same class.

Status: Ongoing. Initiation: voluntary: firm initiated. Philips North America has 30 enforcement events on this register, with a median of 2 product records per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Philips North America, Cambridge, MA.

Reason for recall

"During a production process, Philips became aware of one IntelliVue power supply with a broken ground bolt upon disconnection of the ground cable from the equipotential ground connector. Loss of electrical grounding may negatively affect the devices electromagnetic immunity and emission."

Distribution

"US Nationwide. Global Distribution."

Product records

Recall numberProductQuantityClassStatusReport date
Z-3249-2024IntelliVue Patient Monitor MX400 (Model Number 866060), MX430 (Model Number 866061), MX450 (Model Number 866062), MX500 (Model Number 866064), and MX550 (Model Number 866066)545 devicesClass IIOngoing2 Oct 2024

Context

87%of 2024 device events are Class II970 events that year
1product record in this eventfirm median: 2
30events on this register for the firm

Other enforcement events for Philips North America

InitiatedProduct (first record)TypeClassRecords
31 Jul 2026Philips Patient Information Center iX REF:866389DeviceClass II2
14 Apr 2026Philips Achieva 1.5T with MR Elastography (MRE). 1. Model Number (REF): 781196. 2. Model Number (REF): 781296.DeviceClass II19
22 Dec 2025Patient Information Center iX; Software Version Number: 4.5.0DeviceClass II1
3 Dec 2025Evolution Upgrade 1.5T. Product Codes (REF): (1) 782148, (2) 782116. MR systems with SW version R11.1 and R12.1.DeviceClass II13
27 Oct 2025Azurion R3.0. Model Number 722234. Commercial Name: Azurion 7 M20. INTERVENTIONAL FLUOROSCOPIC XRAY SYSTEMDeviceClass II1
12 Sep 2025Cardiac Workstation 5000; Model Number: 860439;DeviceClass II2
30 Jun 2025Achieva 3.0T; Model Numbers (REF): (1) 781177, (2) 781277, (3) 781278, (4) 781344, (5) 781345;DeviceClass II19
29 May 2025Achieva XR Product Numbers: (1) 781153, (2) 781253;DeviceClass II9
28 Feb 2024Patient Information Center iX (PIC iX), Model Numbers 866389, 866390 (PIC iX Expand), and 866424 (PIC iX Hardware) runniDeviceClass II2
3 Jan 2024Achieva 1.5T. Model (REF) Numbers 781196, 781343, 781296.DeviceClass II12

All 30 events for Philips North America

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "During a production process, Philips became aware of one IntelliVue power supply with a broken ground bolt upon disconnection of the ground cable from the equipotential ground connector. Loss of electrical grounding may negatively affect the devices electromagnetic immunity and emission."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "US Nationwide. Global Distribution."

Is the recall still ongoing?

FDA lists the status as Ongoing. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.